LIVMARLI Now Approved in Japan for ALGS and PFIC
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and ...
Live Science16h
'We will fight for him': Author John Green meets Henry Reider, a young tuberculosis patient with drug-resistant disease
"At the time, I knew almost nothing about TB. To me, it was a disease of history — something that killed depressive ...
Taiwan News1d
Xenotransplantation Market Valued at USD 29.9 Billion in 2023, Projected to Grow at an 8.9% CAGR Through 2032
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8720 ...
Woman Told She Has 'Three Weeks to Live' Due to Brain Tumors Outlives Prognosis by Years: 'I Appreciate the Little Days'
In 2021, a breast cancer survivor thought it was "ridiculous" to go to the doctor for pins and needles — then she learned she ...
Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...
Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval
Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...
GENFIT Announces Completion Of Non-Dilutive Royalty Financing Agreement With Hcrx And Results Of Repurchase Offer To 2025 Oceanes Holders
GENFIT completes a royalty financing of up to €185 million with HCRx after unanimous OCEANE bondholder approval, triggering a € ...
GENFIT S.A.: GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders
GENFIT completes a royalty financing of up to €185 million with HCRx after unanimous OCEANE bondholder approval, triggering a €130 million upfront payment with potential for an additional €55 million ...
Inflammation and Scarring of the Bile Ducts: Causes, Diagnosis, and Treatments
Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...
GB News on MSN9d
From bedwetting to writer's cramp, the success rate of EVERY benefit claim EXPOSED as Labour wields axe
From wetting the bed to acne, we have crunched the numbers on the success rate of every single disability claim. It comes ...
Karolinska Development AB (publ): Karolinska Development's portfolio company Umecrine Cognition provides update on ongoing Phase 1b/2a clinical study
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has provided an update regarding the ongoing clinical ...
Taiwan News9d
Karolinska Development’s portfolio company Umecrine Cognition provides update on ongoing Phase 1b/2a clinical study
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has provided an update regarding the ongoing clinical phase 1b/2a trial evaluating the ...